CHDI has begun working with 11 pediatric primary care practices to adopt the American Academy of Pediatrics’ primary care guidelines for Attention-Deficit/Hyperactivity Disorder (ADHD).
The practices are currently receiving on-site training from CHDI about the evaluation, diagnosis, and treatment of ADHD in children and adolescents. Participating practices complete monthly data collection to assess their progress in improving care for children with attention disorders.
The one-year project (which began in August 2017) is managed by the American Academy of Pediatrics and supported by an independent grant from Pfizer, Inc. It is one five projects selected nationally to increase adoption of national guidelines developed by the American Academy of Pediatrics on ADHD (Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of ADHD in Children and Adolescents). Through the grant, CHDI is working with Connecticut Children’s Office for Community Child Health (OCCH), the Yale Child Study Center and the Connecticut Family Support Network to promote the following three practice changes:
- Improving rates of follow up of parents’ concerns about inattention with initiation of validated assessment tools for ADHD
- Ensuring that a diagnosis of ADHD includes assessment for co-existing conditions
- Using medical home strategies for all children diagnosed with ADHD, including family support and linkage with community services
The training and practice quality components of the project will remain active beyond the funding period for widespread distribution to practices in Connecticut through CHDI’s EPIC program. CHDI’s Susan Macary is the project manager for the grant.